Spaulding Clinical Research, LLC
Melanie Fein, M.D., CPI has over 18 years of experience in the field of clinical trials. Melanie has held various roles throughout their career, including Director of Medical Strategy and Oversight at Spaulding Clinical Research, LLC, and Medical Director/Principal Investigator at High Point Clinical Trials Center and Covance Clinical Pharmacology Services/Daytona CRU. Melanie has also worked as a Research Physician Consultant and Subinvestigator at Comprehensive NeuroScience. Melanie is highly experienced in the set-up and implementation of efficient early phase research facilities, having conducted over 350 studies.
Melanie Fein M.D., CPI attended the University of Miami Miller School of Medicine. The specific years of their attendance are not provided. Melanie also completed their undergraduate medical degree, MBBCH, at the University of the Witwatersrand.
In terms of certifications, Melanie Fein M.D., CPI obtained the Certified Physician Investigator (CPI) certification in October 2007. The institution from which they obtained this certification is not specified. Additionally, they obtained the American Board Of Family Medicine certification in 2003 from the American Board of Family Medicine.
This person is not in any teams
Spaulding Clinical Research, LLC
Founded in 2007, Spaulding Clinical is a full-service, state-of-the-art paperless Phase I clinical pharmacology unit. Our facility, originally a hospital, features fully integrated bedside electronic data capture and sets the standard for patient care. We specialize in IND-enabling clinical pharmacology studies, cardiovascular safety, and clinical proof of concept. We provide expertise on study design, offering in-house medical writing, clinical data management, biostatistics, project management, clinical laboratory, and PK/PD analysis. For high-quality data to inform your decisions, Think Spaulding First. To learn more, visit spauldingclinical.com.